EpCAM is associated with oncogenesis and is strongly expressed in various types of human epithelial carcinoma, such as lung, breast, prostate, ovarian, cervical, and colorectal cancer (CRC), and the expression of EpCAM is related to the degree of disease, suggesting that it may be a promising target for cancer diagnosis and treatment [70]. Here, EPCAM is linked to colorectal carcinoma.